NNC0471-0119

N/A

Report date: 2025/02/10 17:41:25

Base Information

Drug NameNNC0471-0119
Drug Alias NameNNC-0471-0119NNC 0471-0119NN1471NN-1471NNC0471 0119
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionOrnithine decarboxylase stimulantsReceptor protein-tyrosine kinase stimulants
TargetsOrnithine decarboxylaseReceptor protein-tyrosine kinase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk A/S
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A